ACTINIUM PHARMACEUTICALS, INC. (ATNM) valuation
Share price $1.00 · As of last filing 2026-03-31
Special situation detected — historical normalisation may not reflect go-forward economics.
EPV and Reverse-DCF outputs below are anchored on history that
no longer represents the entity going forward
(net cash > 50% of market cap)
.
Inspect the balance sheet, recent 8-K filings, and the cards
above before relying on these models.
- net cash > 50% of market cap. Net cash $40.6M (cash $42.1M − debt $1.5M) = 130.1% of market cap $31.2M